Collaborative Atorvastatin Diabetes Study - CARDS

Description:

The goal of the Collaborative Atorvastatin Diabetes Study (CARDS) trial was to determine the effectiveness of the lipid-lowering agent atorvastatin in reducing cardiovascular events and death among diabetic patients with at least one heart disease risk factor, but without elevated cholesterol.